AU2006217608A1 - Oxidative stress measurement device and related methods - Google Patents

Oxidative stress measurement device and related methods Download PDF

Info

Publication number
AU2006217608A1
AU2006217608A1 AU2006217608A AU2006217608A AU2006217608A1 AU 2006217608 A1 AU2006217608 A1 AU 2006217608A1 AU 2006217608 A AU2006217608 A AU 2006217608A AU 2006217608 A AU2006217608 A AU 2006217608A AU 2006217608 A1 AU2006217608 A1 AU 2006217608A1
Authority
AU
Australia
Prior art keywords
oxidative stress
optical
disease
patient
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006217608A
Other languages
English (en)
Inventor
Dirk Bandilla
David H. Burns
Scott Rosendahl
Hyman Schipper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2006217608A1 publication Critical patent/AU2006217608A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/726—Details of waveform analysis characterised by using transforms using Wavelet transforms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Developmental Disabilities (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
AU2006217608A 2005-02-22 2006-02-21 Oxidative stress measurement device and related methods Abandoned AU2006217608A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65449705P 2005-02-22 2005-02-22
US60/654,497 2005-02-22
PCT/IB2006/000335 WO2006090228A1 (en) 2005-02-22 2006-02-21 Oxidative stress measurement device and related methods

Publications (1)

Publication Number Publication Date
AU2006217608A1 true AU2006217608A1 (en) 2006-08-31

Family

ID=36570391

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006217608A Abandoned AU2006217608A1 (en) 2005-02-22 2006-02-21 Oxidative stress measurement device and related methods

Country Status (6)

Country Link
US (2) US20070054347A1 (enExample)
EP (1) EP1853894A1 (enExample)
JP (1) JP2008531987A (enExample)
AU (1) AU2006217608A1 (enExample)
CA (1) CA2598529A1 (enExample)
WO (1) WO2006090228A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070162992A1 (en) * 2006-01-09 2007-07-12 Mcgill University Metabolomic determination in assisted reproductive technology
US20090287064A1 (en) * 2008-05-15 2009-11-19 Medical Interactive Education, Llc Computer implemented cognitive self test
ATE545014T1 (de) * 2009-04-30 2012-02-15 Hoffmann La Roche Verfahren zur detektion von verunreinigungen einer optischen messküvette
EP2700933A1 (en) * 2012-08-20 2014-02-26 Consejo Superior De Investigaciones Científicas (CSIC) Raman, infrared, or Raman-Infrared analysis of peripheral blood plasma protein structure and its relation to cognitive development in Alzheimer's disease
WO2014205426A1 (en) * 2013-06-21 2014-12-24 Imigene, Inc. Blood analysis
JP6533076B2 (ja) * 2014-03-26 2019-06-19 アークレイ株式会社 還元力の分析方法および還元力の分析試薬
US10542961B2 (en) 2015-06-15 2020-01-28 The Research Foundation For The State University Of New York System and method for infrasonic cardiac monitoring
US10837926B2 (en) * 2017-09-01 2020-11-17 Case Western Reserve University Multi-modal spectroscopic analysis
CN115307715B (zh) * 2022-08-09 2025-08-01 南昌航空大学 一种基于sagnac光纤声传感系统的改进小波去噪方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712165A (en) * 1994-08-22 1998-01-27 Beth Israel Hospital Administration Method and apparatus for detecting hydrocarbon oxidation
US7603166B2 (en) * 1996-09-20 2009-10-13 Board Of Regents University Of Texas System Method and apparatus for detection of vulnerable atherosclerotic plaque
AU769547B2 (en) * 1998-05-29 2004-01-29 Nikken Foods Co., Ltd. Use of oxidative stress diagnostic plot as a health indicator for assessing oxidative stress and its control in humans
JP2003530130A (ja) * 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
JP2003083977A (ja) * 2001-09-12 2003-03-19 Mitsubishi-Tokyo Pharmaceuticals Inc 酸化ストレスの測定方法
JP3916944B2 (ja) * 2001-12-12 2007-05-23 ハウス食品株式会社 神経細胞保護物質
US6660736B2 (en) * 2002-03-27 2003-12-09 Hoffmann-La Roche Inc. Phthalimido derivatives and a process for their preparation
JP2003310621A (ja) * 2002-04-19 2003-11-05 Nikken Foods Co Ltd 酸化ストレス特性の診断分析図、これを用いた酸化ストレス特性の診断方法及び機能性食品の評価・開発方法並びに酸化ストレス特性の改善に用いられる機能性食品
JP3735816B2 (ja) * 2002-12-09 2006-01-18 日研フード株式会社 酸化ストレス評価のための健康指標としての酸化ストレス診断分析図を使用して酸化ストレスを評価する方法
US20040121305A1 (en) * 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
DE102004061064A1 (de) * 2004-12-18 2006-06-29 Roche Diagnostics Gmbh Verfahren und Vorrichtung zur spektroskopischen Untersuchung von Körperflüssigkeiten und Gewebeproben hinsichtlich eines erhöhten Alzheimerverdachts

Also Published As

Publication number Publication date
US20070054347A1 (en) 2007-03-08
US20120173154A1 (en) 2012-07-05
WO2006090228A1 (en) 2006-08-31
CA2598529A1 (en) 2006-08-31
EP1853894A1 (en) 2007-11-14
JP2008531987A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
US20120173154A1 (en) Oxidative stress measurement device and related methods
US20230098156A1 (en) Method and apparatus for determining markers of health by analysis of blood
Ryzhikova et al. Raman spectroscopy and machine learning for biomedical applications: Alzheimer’s disease diagnosis based on the analysis of cerebrospinal fluid
Mordechai et al. Early diagnosis of Alzheimer's disease using infrared spectroscopy of isolated blood samples followed by multivariate analyses
US12303247B2 (en) Methods and tools for diagnosing insulin resistance and assessing health status using NMR relaxation times for water
US20210364421A1 (en) Method and apparatus for determining markers of health by analysis of blood
US8238993B2 (en) Determination of a measure of a glycation end-product or disease state using tissue fluorescence lifetime
US20050148834A1 (en) Determination of a measure of a glycation end-product or disease state using tissue fluorescence
US20120078075A1 (en) Determination of a measure of a glycation end-product or disease state using tissue fluorescence in combination with one or more other tests
US20050090750A1 (en) Determination of disease state using Raman Spectroscopy of tissue
Cai et al. Comparing machine learning‐derived MRI‐based and blood‐based neurodegeneration biomarkers in predicting syndromal conversion in early AD
Burns et al. Near-infrared spectroscopy of blood plasma for diagnosis of sporadic Alzheimer's disease
Tangwanichgapong et al. Identification of molecular biomarkers in human serum for chronic kidney disease using attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy
Xiang et al. Diabetes‐associated periodontitis molecular features in infrared spectra of gingival crevicular fluid
Carmona et al. Infrared spectroscopic analysis of mononuclear leukocytes in peripheral blood from Alzheimer’s disease patients
Mitchell et al. Optimization of sepsis risk assessment for ward patients
EP3284408A2 (en) Sampler and method of parameterizing digital circuits and non-invasive determination of the concentration of several biomarkers simultaneously and in real time
Arévalo et al. Detection of Alzheimer’s by machine learning-assisted vibrational spectroscopy in human cerebrospinal fluid
RU2247379C1 (ru) Способ дифференциальной диагностики деструктивных изменений при различных формах острого холецистита
EP1882927A1 (en) Method and device for diagnosing chronic fatigue syndrome (cfs) by using near infrared spectrum
Habadi et al. Alzheimer’s Disease: The Relative Importance Diagnostic
KN et al. Early Diagnosis of Alzheimer’s Disease: β-Amyloid and Tau Detection in Body Fluids
Bandzevičiūtė et al. Infrared spectroscopic determination of dry infectious and normal cerebrospinal fluids
Maryam Habad et al. Alzheimer’s Disease: The Relative Importance Diagnostic
Henly Predicting Cognitive Decline: Advances in Pre-Clinical Diagnosis of Alzheimer’s Disease

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application